放射治疗引起免疫细胞死亡和瘤微环境中的代谢转变:对免疫疗法的影响
Zi-Shan Hang1, Yue-Ying Huang1, An Song2
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
International journal of medical sciences
|August 6, 2025
概括
放射治疗影响瘤代谢和细胞死亡,影响瘤的微环境. 了解这些分子变化,包括免疫细胞死亡,是开发向纳米药物和免疫疗法组合的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 放射治疗是一种主要的癌症治疗方法,在分子水平上运作.
- 瘤微环境 (TME) 在放射治疗期间发生显著变化,影响新陈代谢和免疫反应.
- 代谢变化和免疫细胞死亡 (ICD) 是TME内的放射治疗影响的关键因素.
研究的目的:
- 审查目前关于放射治疗诱导的代谢变化和ICD的研究结果.
- 探索放射治疗诱导的ICD的机械路径.
- 提供有关TME的现状和放射治疗和免疫治疗的临床进展的见解.
主要方法:
- 关于放射治疗,TME,新陈代谢和ICD的最新研究的文献综述.
- 对放射治疗对瘤细胞和免疫系统影响的分子机制的分析.
- 综合关于临床应用和不良事件管理的信息.
主要成果:
- 放射治疗调节瘤代谢以支持细胞存活和修复,抵消细胞死亡.
- 放射治疗可以诱导特定形式的ICD,如热亡,死亡和铁亡,从而增强抗瘤免疫力.
- 了解这些过程对于优化放射治疗和组合疗法的疗效至关重要.
结论:
- 代谢重编程和ICD诱导是放射治疗对TME影响的核心.
- 针对代谢途径和了解ICD机制对于开发先进的纳米药物至关重要.
- 进一步研究放射治疗与免疫治疗的结合,包括管理副作用是有必要的.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


